云南白药集团股份有限公司2025年第一次临时股东大会决议公告

Core Points - The company held its first extraordinary general meeting of shareholders in 2025 on September 15, 2025, with both on-site and online voting options available [3][5] - A total of 1,432 shareholders attended the meeting, representing 1,123,338,901 shares, which is 62.9582% of the total voting shares [6] - The meeting approved two key resolutions: the change of the company's 2025 audit institution and the special dividend plan for 2025, both receiving overwhelming support from shareholders [10][12] Meeting Details - The meeting was convened by the company's 10th Board of Directors and was held at the company's headquarters in Kunming, Yunnan Province [4][5] - Voting was conducted through a combination of on-site and online methods, with specific time slots designated for online voting [3] Attendance - The overall attendance included 1,432 shareholders, with 76 attending in person and 1,356 participating via online voting [6] - Among the attendees, 1,428 were small shareholders, representing 61,451,537 shares, which is 3.4441% of the total voting shares [8] Voting Results - The first resolution regarding the change of the audit institution received 99.9189% approval from the voting shares [9] - The second resolution concerning the special dividend plan was approved with 99.9840% of the voting shares in favor [11] Legal Opinion - The legal opinion provided by Beijing Deheng (Kunming) Law Firm confirmed that the meeting's procedures and resolutions complied with legal and regulatory requirements [13]